Почетна › Колоректални карцином › Пенсилванија › Philadelphia
Kliničke studije za Колоректални карцином u gradu Philadelphia, PA
Jedna studija za Колоректални карцином traži učesnike na lokaciji u gradu Philadelphia ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Тражи се учесникФаза 1
- Sidney Kimmel Cancer Center, Philadelphia
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Тражи се учесникФаза 1/2
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Тражи се учесникФаза 3Здраве особе су добродошле
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 ми удаљено
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 ми удаљено
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Тражи се учесникОпсервациона студија
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 ми удаљено
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Тражи се учесникФаза 3
- Clinical Study Site, Philadelphia
- Clinical Study Site, Philadelphia
- Clinical Study Site, Philadelphia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 ми удаљено
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Тражи се учесникФаза 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Тражи се учесникФаза 3
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Тражи се учесникФаза 3
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Alliance Cancer Specialists at Main Line, Penn Wynne · 6 ми удаљено
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- Fox Chase Cancer Center, Philadelphia
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Тражи се учесникФаза 2
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 ми удаљено
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 ми удаљено
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- Sydney Kimmel Cancer Center, Philadelphia
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- University of Pennsylvania, Philadelphia
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Тражи се учесникФаза 3
- University of Pennsylvania, Philadelphia
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
Тражи се учесникРана фаза 1
- Fox Chase Cancer Center, Philadelphia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
Тражи се учесникФаза 1
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Тражи се учесникФаза 2
- Thomas Jefferson University - Sidney Kimmel Comprehensive Cancer Center, Philadelphia
TCR1188-ABC Cells in KRAS-mutated Cancers
Тражи се учесникФаза 1
- University of Pennsylvania, Philadelphia
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Тражи се учесникФаза 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275407, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #98, Philadelphia
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- GSK Investigational Site, Philadelphia
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Тражи се учесникФаза 3
- Fox Chase Cancer Center, Philadelphia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Тражи се учесникФаза 1/2
- Hospital of the University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Тражи се учесникФаза 1/2
- Children's Hospital of Philadelphia, Philadelphia
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Тражи се учесникОпсервациона студија
- University of Pennsylvania, Philadelphia
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Thomas Jefferson University, Philadelphia
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Тражи се учесникФаза 1
- Jefferson University Hospitals, Philadelphia
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Тражи се учесникФаза 2
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Тражи се учесникФаза 4
- Jefferson Health, Philadelphia
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Тражи се учесникФаза 2
- Alliance Cancer Specialists, Wynnewood · 7 ми удаљено
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Тражи се учесникФаза 1/2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Тражи се учесникФаза 4
- Albert Einstein Healthcare Network, Philadelphia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Тражи се учесникОпсервациона студија
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 ми удаљено
Collection of Samples USOPTIVAL Study
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- University of Pennsylvania, Philadelphia
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Тражи се учесникФаза 3
- Perelman Center for Advanced Medicine, Philadelphia
Studije za Колоректални карцином u drugim gradovima
- Houston, TX101 студија
- New York City, NY86 студија
- Nashville, TN67 студија
- Boston, MA62 студија
- Los Angeles, CA61 студија
- Arlington, VA54 студија
- St. Louis, MO51 студија
- San Antonio, TX43 студија
- Grand Rapids, MI40 студија
- Baldwin Park, CA37 студија
- Tampa, FL36 студија
- Seattle, WA35 студија
Ostale studije u gradu Philadelphia
- Рак (све врсте)57 студија
- Рак дојке51 студија
- Немалоклетни карцином плућа49 студија
- Рак јајника47 студија
- Метастатски карцином42 студија
- Рак простате41 студија
- Рак плућа36 студија
- Akutna mijeloidna leukemija33 студија
- Затајење срца31 студија
- Карцином ендометријума29 студија
- Рак панкреаса26 студија
- ХОБП26 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.